PSU pharma company, Bengal Chemicals and Pharmaceuticals, has obtained licence to manufacture hydroxychloroquine (HCQ), an anti-malaria drug now found being used to treat for coronavirus infection.
US President Donald Trump's strong advocacy of Hydroxychloroquine for treating COVID-19 patients has rekindled hopes of cinchona planters of Darjeeling hills as the tree's bark is used for production of quinine, another frontline anti-malaria medicine. Beginning in 1862 in Darjeeling, cinchona plantations flourished over the next several decades in the verdant hills as Malaria sent chill down the spine of people in vast swathes of the country. And it still does.
La Jolla Pharmaceutical Company was granted an Orphan Drug Designation from the FDA for the Investigational Drug Product, LJPC-0118 (artesunate), for the treatment of malaria. LJPC-0118, artesunate, demonstrated to be superior to quinine in reducing mortality in patients with falciparum malaria infection
Ibuprofen For a Longer Life?